A previous CRC study correlated the mRNA expression of CD44 and CD133 with the existence of synchronous hepatic metastases, revealing that the genes’ expression levels were highly co-expressed and decreased from hepatic metastasis tissue to CRC tissue, both preceding normal mucosa. This evidence concerns the gene CD44 and colorectal carcinoma.